The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Misdiagnosis of Hereditary Amyloidosis as AL (Primary) Amyloidosis
Open accessAbstract
BACKGROUND: Hereditary, autosomal dominant amyloidosis, caused by mutations in the genes encoding transthyretin, fibrinogen A alpha-chain, lysozyme, or apolipoprotein A-I, is thought to be extremely rare and is not routinely included in the differential diagnosis of systemic amyloidosis unless there is a family history. METHODS: We studied 350 patients with systemic amyloidosis, in whom a diagnosis of the light-chain (AL) type of the disorder had been suggested by clinical and laboratory findings and by the absence of a family history, to assess whether they had amyloidogenic mutations. RESULTS: Amyloidogenic mutations were present in 34 of the 350 patients (9.7 percent), most often in the genes encoding fibrinogen A alpha-chain (18 patients) and transthyretin (13 patients). In all 34 of these patients, the diagnosis of hereditary amyloidosis was confirmed by additional investigations. A low-grade monoclonal gammopathy was detected in 8 of the 34 patients (24 percent). CONCLUSIONS: A genetic cause should be sought in all patients with amyloidosis that is not the reactive systemic amyloid A type and in whom confirmation of the AL type cannot be obtained.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance
Kyle, R. A., Therneau, T. M., Rajkumar, S. V., Offord, J. R., Larson, D. R., Plevak, M. F., & Melton, L. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa01133202 · Cited by 1,475
Primary systemic amyloidosis: clinical and laboratory features in 474 cases.
Kyle, R. A., & Ma, G. (1995) · PubMed · Cited by 1,255
ON THE BINDING OF CONGO RED BY AMYLOID
PUCHTLER, H., SWEAT, F., & LEVINE, M. (1962) · Journal of Histochemistry & Cytochemistry · doi:10.1177/10.3.355 · Cited by 1,128
Kyle, R. A., Gertz, M. A., Greipp, P. R., Witzig, T. E., Lust, J. A., Lacy, M. Q., & Therneau, T. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361702 · Cited by 688
Human lysozyme gene mutations cause hereditary systemic amyloidosis
Pepys, M. B., Hawkins, P. N., Booth, D. R., Vigushin, D. M., Tennent, G. A., Soutar, A. K., Totty, N., Nguyen, O., Blake, C. C. F., Terry, C. J., et al. (1993) · Nature · doi:10.1038/362553a0 · Cited by 657
Self-citationHolmgren, G., Steen, L., Suhr, O., Ericzon, B.-G., Groth, C.-G., Andersen, O., Wallin, B. G., Seymour, A., Richardson, S., Hawkins, P. N., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)93127-m · Cited by 579
Self-citationVariant-Sequence Transthyretin (Isoleucine 122) in Late-Onset Cardiac Amyloidosis in Black Americans
Jacobson, D. R., Pastore, R. D., Yaghoubian, R., Kane, I., Gallo, G., Buck, F. S., & Buxbaum, J. N. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702133360703 · Cited by 554
Evaluation of Systemic Amyloidosis by Scintigraphy with123I-Labeled Serum Amyloid P Component
Hawkins, P. N., Lavender, J. P., & Pepys, M. B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008233230803 · Cited by 533
Self-citationVariant apolipoprotein AI as a major constituent of a human hereditary amyloid
Nichols, W. C., Dwulet, F. E., Liepnieks, J., & Benson, M. D. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80909-4 · Cited by 233
TAN, S. Y., & PEPYS, M. B. (1994) · Histopathology · doi:10.1111/j.1365-2559.1994.tb00001.x · Cited by 230
Self-citationHereditary renal amyloidosis associated with a mutant fibrinogen α–chain
Benson, M. D., Liepnieks, J., Uemichi, T., Wheeler, G., & Correa, R. (1993) · Nature Genetics · doi:10.1038/ng0393-252 · Cited by 219
Benson, M. D., & Uemichi, T. (1996) · Amyloid · doi:10.3109/13506129609014354 · Cited by 187
Benson, M. D., Liepnieks, J. J., Yazaki, M., Yamashita, T., Asl, K. H., Guenther, B. D., & Kluve‐Beckerman, B. (2001) · Genomics · doi:10.1006/geno.2000.6499 · Cited by 157
Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis.
Soutar, A. K., Hawkins, P. N., Vigushin, D. M., Tennent, G. A., Booth, S. E., Hutton, T., Nguyen, O., Totty, N. F., Feest, T., & Hsuan, J. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7389 · Cited by 143
Self-citationSequence Communication: Tabulation of transthyretin (TTR) variants as of 1/1/2000
Connors, L. H., Richardson, A. M., Théberge, R., & Costello, C. E. (2000) · Amyloid · doi:10.3109/13506120009146826 · Cited by 132
Hereditary Amyloid Cardiomyopathy Caused by a Variant Apolipoprotein A1
Asl, K. H., Liepnieks, J. J., Asl, K. H., Uemichi, T., Moulin, G., Desjoyaux, E., LOIRE, R., Delpech, M., Grateau, G., & Benson, M. D. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65268-6 · Cited by 112
Hereditary renal amyloidosis with a novel variant fibrinogen.
Uemichi, T., Liepnieks, J. J., & Benson, M. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117027 · Cited by 98
Sousa, M. M., Vital, C., Ostler, D., Fernandes, R., Pouget-Abadie, J., Carles, D., & Saraiva, M. J. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65064-x · Cited by 97
Gillmore, J. D., Booth, D. R., Rela, M., Heaton, N. D., Rahman, V., Stangou, A. J., Pepys, M. B., & Hawkins, P. N. (2000) · QJM · doi:10.1093/qjmed/93.5.269 · Cited by 88
Self-citationHawkins, P. N. (1994) · Clinical Science · doi:10.1042/cs0870289 · Cited by 83
Self-citationFamilial nephropathic systemic amyloidosis caused by apolipoprotein Al variant Arg26
Vigushin, D. M., Gough, J., Allan, D. R., Alguacil, A., Penner, B., Pettigrew, N. M., Quinonez, G. E., Bernstein, K. N., Booth, S. E., Booth, D. R., et al. (1994) · QJM · doi:10.1093/oxfordjournals.qjmed.a068909 · Cited by 53
Self-citation
Cited by
Molecular Mechanisms of Amyloidosis
Merlini, G., & Bellotti, V. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023144 · Cited by 1,920
Gertz, M. A., Comenzo, R., Falk, R. H., Fermand, J. P., Hazenberg, B. P., Hawkins, P. N., Merlini, G., Moreau, P., Ronco, P., Sanchorawala, V., et al. (2005) · American Journal of Hematology · doi:10.1002/ajh.20381 · Cited by 1,428
Self-citationNatural History and Outcome in Systemic AA Amyloidosis
Lachmann, H. J., Goodman, H. J. B., Gilbertson, J. A., Gallimore, J. R., Sabin, C. A., Gillmore, J. D., & Hawkins, P. N. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070265 · Cited by 1,032
Self-citationPerugini, E., Guidalotti, P. L., Salvi, F., Cooke, R. M. T., Pettinato, C., Riva, L., Leone, O., Farsad, M., Ciliberti, P., Bacchi-Reggiani, L., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.073 · Cited by 981
Diagnosis and Management of the Cardiac Amyloidoses
Falk, R. H. (2005) · Circulation · doi:10.1161/circulationaha.104.489187 · Cited by 791
Metadata
- Authors
- Lachmann, H. J., Booth, D. R., Booth, S. E., Bybee, A., Gilbertson, J. A., Gillmore, J. D., Pepys, M. B., & Hawkins, P. N.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-06-06
- Volume
- 346
- Issue
- 23
- Pages
- 1786-1791
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2071134058
- Cited by
- 680
- References
- 21
- FWCI
- 9.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.